Oral Abstract: Improving survival following pediatric kidney transplant
Friday September 19, 2025 from 13:35 to 15:05
MOA 6
Moderators
Lectures
-
225.1 Successful use of daratumumab (Anti-CD38) for the treatment of pediatric post-transplant proteinuric diseases: A case seriesDechu Puliyanda, United States
-
225.2 Tolerating Unfavorable Donor Criteria in Pediatric Kidney Transplantation: A Retrospective UNOS AnalysisZachary Oatley, United States
-
225.3 Low-Density Lipoprotein Apheresis for Recurrent Nephrotic Syndrome in Pediatric Kidney Recipients: A Systematic Review and Meta-AnalysisPriya Verghese, United States
-
225.4 Age-dependent differences in pediatric versus adult kidney transplantation: ımpaired VEGF and NO signaling weaken microvascular ıntegrity and threaten renal graft survivalBinnaz Handan Ozdemir, Turkey
-
225.5 Risk stratification of chronic kidney allograft failure in donor-recipient (D-R) pairsDr. Agnieszka Swiatecka-Urban, United States
-
225.6 Genetic Screening and Prognosis of Pediatric Patients with Primary Nephrotic Syndrome after Renal TransplantationDr. Yonghua Feng, People's Republic of China
-
225.7 Long-term Outcomes of Paediatric Kidney Transplants from DCD donors are comparable to those from DBD donors: a 33-year Comparative OPTN studyMr. Nicos Kessaris, United Kingdom
-
225.8 Long-term outcomes of right versus left kidney transplants over a 33-year period in the USA – a comparative studyMr. Nicos Kessaris, United Kingdom
-
225.9 Impaired renal function at 1-year after for-cause biopsy affected long-term graft survival in pediatric kidney transplant recipientsDr. Longshan Liu, People's Republic of China